BioTime (BTX) CEO Dr. Michael West To Present At 9th Annual Stem Cell Summit
2/18/2014 6:49:53 AM
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 9th Annual Stem Cell Summit in New York. Dr. West will speak in the session “Disrupting the Pharma Model with Allogeneic Stem Cell Therapies” on February 18, 2014, starting at 9:05 a.m. EST.
Help employers find you! Check out all the jobs and post your resume.
comments powered by